InsidersTradesSigma
Follow the Neuphoria Therapeutics Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). The latest transaction was filed on 23 October 2025 (Acquisition). Among the most active insiders: Lynx1 Capital Management LP. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Neuphoria Therapeutics Inc. 是一家专注于开发神经系统疾病创新疗法的公司。它在XNAS市场上市。